About SPL
A biotechnology company applying its proprietary dendrimer technology to develop improved pharmaceutical formulations targeting cancer and other serious diseases.
All News for SPL
No news articles found for SPL yet.
A biotechnology company applying its proprietary dendrimer technology to develop improved pharmaceutical formulations targeting cancer and other serious diseases.
No news articles found for SPL yet.
Get alerts when news about SPL is published